According to DataM Intelligence, the Insulin Delivery Devices Market Size reached USD 20.26 billion in 2024 and is projected ...
Access to automated insulin delivery systems for Type 1 diabetes patients is uneven, with lower usage among Black youth. Barriers and solutions discussed.
Medtronic has commercially launched its MiniMed 780G system in the US, now integrated with Abbott’s Instinct sensor.
Global Insulin Delivery Device Market Growth Overview The global insulin delivery device market is poised to expand at a CAGR of around 8% during the forecast period, driven by the increasing global ...
The global wearable drug delivery devices market growth is driven by rising chronic diseases and advanced connected healthcare solutions. North America leads while Asia Pacific delivers the fastest ...
The medtech firm plans to launch its next flagship patch-pump in 2027, and its first fully closed loop system for Type 2 ...
Everyday Health on MSN
Should You Be Using Automated Insulin Delivery (AID) for Type 1 Diabetes?
AID systems combine an insulin pump with a continuous glucose monitor to automatically adjust insulin levels throughout the ...
The MarketWatch News Department was not involved in the creation of this content. DELRAY BEACH, Fla., June 25, 2025 /PRNewswire/ -- The global Insulin Delivery Device Market, valued at US$32.6 billion ...
DUBLIN--(BUSINESS WIRE)--The "Global Insulin Delivery Devices Market by Type (Insulin Pens [Reusable, Disposable], Insulin Pumps (Tethered, Tubeless), Insulin ...
When it comes to devices used by consumers, design and user friendliness can mean the difference between success and failure. Historically, though, that has not been true in the healthcare world, ...
NEW YORK, Aug. 18, 2021 /PRNewswire/ -- From $7,276.9 million in 2020, the size of the global home-use insulin delivery devices market will increase to $19,087.6 million in 2030, at a 10.2% CAGR ...
BRIDGEWATER, N.J., May 04, 2017 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX) today announced that clinical data demonstrating that use of the V-Go® Wearable Insulin Delivery Device ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results